Markets:

Overview

News

Currencies

International

Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

18.01 +0.60 (+3.45%)

Streaming Delayed Price Updated: 2:38 PM EDT, Aug 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fortrea Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

1 Healthcare Stock to Consider Right Now and 2 Facing Headwinds

November 13, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...

Via StockStory

Topics Stocks

5 Insightful Analyst Questions From Fortrea’s Q3 Earnings Call

November 12, 2025

Fortrea’s third quarter results were met with a significant positive response from the market, as robust demand across its clinical pharmacology and clinical development businesses drove revenue...

Via StockStory

Topics Earnings World Trade

Q3 Earnings Highs And Lows: Fortrea (NASDAQ:FTRE) Vs The Rest Of The Drug Development Inputs & Services Stocks

November 11, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Fortrea (NASDAQ:FTRE) and the...

Via StockStory

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Where Fortrea Holdings Stands With Analysts ↗

October 02, 2025

Via Benzinga

Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

Fortrea Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE

November 07, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

FTRE Q3 Deep Dive: Revenue Outpaces Estimates, Margin Expansion Remains a Focus

November 06, 2025

Clinical research company Fortrea Holdings (NASDAQ:FTRE) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 3.9% year on year to $701.3 million. The company’s...

Via StockStory

Why Fortrea (FTRE) Stock Is Trading Up Today

November 05, 2025

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 25.3% in the morning session after the company reported third-quarter financial results that showed stronger-than-expected...

Via StockStory

Topics Artificial Intelligence Earnings Initial Public Offering

When Bad News is Good News: Fortrea and Flowco Defy Earnings Logic

November 05, 2025

In a financial landscape often dictated by strict adherence to earnings forecasts, recent market movements have showcased a fascinating deviation from traditional expectations. Public companies like...

Via MarketMinute

Topics Earnings Economy Energy

FORTREA HOLDINGS INC (NASDAQ:FTRE) Reports Q3 2025 Revenue Beat and Adjusted EPS Miss ↗

November 05, 2025

Fortrea posts Q3 2025 results with a revenue beat but an adjusted EPS miss. The CRO raises its full-year revenue guidance and reports a strong book-to-bill ratio of 1.13x.

Via Chartmill

Fortrea (NASDAQ:FTRE) Beats Q3 Sales Expectations

November 05, 2025

Clinical research company Fortrea Holdings (NASDAQ:FTRE) announced better-than-expected revenue in Q3 CY2025, with sales up 3.9% year on year to $701.3 million. The company’s full-year revenue guidance...

Via StockStory

Fortrea Reports Third Quarter 2025 Results

November 05, 2025

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea (FTRE) Reports Q3: Everything You Need To Know Ahead Of Earnings

November 03, 2025

Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be announcing earnings results this Wednesday morning. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

3 Inflated Stocks We Find Risky

October 31, 2025

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...

Via StockStory

3 Unprofitable Stocks We Steer Clear Of

October 27, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

3 Cash-Burning Stocks with Questionable Fundamentals

October 24, 2025

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.

Via StockStory

Why Fortrea (FTRE) Stock Is Trading Up Today

October 20, 2025

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 7.7% in the afternoon session after it commenced a cash tender offer to buy back up to $75.74 million of its outstanding senior...

Via StockStory

Topics Economy Government Initial Public Offering

Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt

October 20, 2025

From Fortrea Holdings Inc

Via GlobeNewswire

3 Unpopular Stocks That Concern Us

October 20, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call

October 15, 2025

From Fortrea Holdings Inc

Via GlobeNewswire

3 Volatile Stocks Walking a Fine Line

October 15, 2025

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...

Via StockStory

Fortrea Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE

October 11, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

Why Fortrea (FTRE) Stock Is Up Today

October 08, 2025

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 6.1% in the afternoon session after Evercore ISI Group raised its price target on the company to $11.00 from a previous $7.00.

Via StockStory

Topics Artificial Intelligence Initial Public Offering World Trade

Why Fortrea (FTRE) Shares Are Sliding Today

September 25, 2025

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 6.3% in the afternoon session after negative news weighed on the broader healthcare sector, including a new U.S. government...

Via StockStory

Topics Artificial Intelligence Initial Public Offering World Trade

Fortrea Appoints William Sharbaugh to Board of Directors

September 22, 2025

From Fortrea Holdings Inc

Via GlobeNewswire

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

September 12, 2025

From Fortrea Holdings Inc

Via GlobeNewswire

3 Small-Cap Stocks We Find Risky

September 11, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Why Fortrea (FTRE) Stock Is Trading Up Today

September 03, 2025

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 4.5% in the afternoon session after Baird raised its price target on the stock to $14.00. This positive analyst action adds to...

Via StockStory

Topics Artificial Intelligence Economy Initial Public Offering

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.